Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018197736) COMPOSITION COMPRISING MIRNAS FOR USE AS A DRUG
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/197736 International Application No.: PCT/ES2018/070325
Publication Date: 01.11.2018 International Filing Date: 24.04.2018
IPC:
Applicants:
UNIVERSIDAD DE GRANADA [ES/ES]; HOSPITAL REAL. AVDA. DEL HOSPICIO S/N 18071 GRANADA, ES
BIOLOGY CENTRE OF THE CZECH ACADEMY OF SCIENCES [CZ/CZ]; Branišovská, 1160/31 370 05 Ceské Budejovice, CZ
Inventors:
HACKENBERG, Michael; ES
KOTSYFAKIS, Michail; GR
MARTINEZ NAVAJAS, Gonzalo; ES
BOULAIZ TASSI, Houria; ES
MARCHAL CORRALES, Juan Antonio; ES
Priority Data:
P20173063524.04.2017ES
Title (EN) COMPOSITION COMPRISING MIRNAS FOR USE AS A DRUG
(FR) COMPOSITION COMPRENANT DES MICRO-ARN DESTINÉE À UN USAGE COMME MÉDICAMENT
(ES) COMPOSICIÓN QUE COMPRENDE MIRNAS PARA SU USO COMO MEDICAMENTO
Abstract:
(EN) The present invention provides a composition comprising at least one oligonucleotide derived from miRNAs from the saliva of the tick Ixodes ricinus. Said composition is useful for treating a disorder selected from cancers, inflammatory diseases, allergies, atopic dermatitis, lupus, asthma, chronic pain, circadian rhythm disorders, metabolic diseases, diabetes, glaucoma, hepatitis, cardiovascular diseases, Parkinson's, neurological and neurodegenerative diseases, and epilepsy.
(FR) La présente invention concerne une composition comprenant au moins un oligonucléotide dérivé de micro-ARN de salive de tique Ixodes ricinus. Cette composition est utile comme méthode de traitement d'un trouble choisi parmi les cancers, les maladies inflammatoires, les allergies, la dermatite atopique, le lupus, l'asthme, les douleurs chroniques, les troubles liés au rythme circadien, les maladies métaboliques, le diabète, le glaucome, l'hépatite, les maladies cardiovasculaires, la maladie de Parkinson, les maladies neurologiques et neurodégénératives, et l'épilepsie.
(ES) La presente invención proporciona una composición que comprende al menos un oligonucleótido derivado de miRNAs de saliva de la garrapata Ixodes ricinus. Dicha composición es útil como método de tratamiento de un trastorno seleccionado entre cánceres, enfermedades inflamatorias, alergias, dermatitis atópica, lupus, asma, dolor crónico, trastornos relacionados con el ritmo circadiano, enfermedades metabólicas, diabetes, glaucoma, hepatitis, enfermedades cardiovasculares, Parkinson, enfermedades neurológicas y neurodegenerativas y epilepsia.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)